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Patients’ experiences of screening for type 2 diabetes:
prospective qualitative study embedded in the ADDITION
(Cambridge) randomised controlled trial
Helen Eborall, post-doctoral research fellow,1 Richard Davies, director of general practice studies,1 Ann-
Louise Kinmonth, professor of general practice,1 Simon Griffin, programme leader,2 Julia Lawton, senior
research fellow3
ABSTRACT
Objectives To provide insight into factors that contribute
to the anxiety reported in a quantitative study of the
psychological effect of screening for type 2 diabetes. To
explore expectations of and reactions to the screening
experience of patients with positive, negative, and
intermediate results.
Design Prospective qualitative interview study of patients
attending a screening programme for type 2 diabetes.
Setting Seven general practices in the ADDITION
(Cambridge) trial in the east of England.
Participants 23 participants (aged 50-69) attending
different stages in the screening process.
Results Participants’ perceptions changed as they
progressed through the screening programme; the
stepwise process seemed to help them adjust
psychologically. The first screening test was typically
considered unimportant and was attended with no
thought about its implications. By the final diagnostic
test, type 2 diabetes was considered a strong possibility,
albeit a “mild” form. After diagnosis, people with screen
detected type 2 diabetes tended to downplay its
importance and talked confidently about their plans to
control it. Participants with intermediate results seemed
uncertain about their diagnosis, and those who screened
negativewere largely unaware of their remaininghigh risk.
Conclusions This study helps in understanding the
limited psychological impact of screening for type 2
diabetes quantified previously, in particular by the
quantitative substudy of ADDITION (Cambridge). The
findings have implications for implementing such a
screening programme in terms of timing and content.
INTRODUCTION
Type 2 diabetesmellitus is a progressive disease,which
can lead to considerable morbidity and mortality as a
result of cardiovascular, renal, and retinal complica-
tions. Disease onset may occur up to 12 years before
clinical diagnosis so many patients are asymptomatic.1
Screening by measuring blood glucose concentrations
can diagnose type 2 diabetes and identify people with
impaired fasting glucose or impaired glucose tolerance
who are at risk of developing the condition.2 Evidence
suggests that earlier detection and treatment may lead
to improved health outcomes,3 and that behavioural
and drug interventions in people with impaired glu-
cose tolerance can reduce progression to type 2
diabetes.4However, it is not clearwhether the potential
population benefits outweigh the possible costs, which
include adverse psychological effects of screening and
subsequent treatment.
The Anglo-Danish-Dutch study of intensive treat-
ment in people with screen detected diabetes in pri-
mary care5 (the ADDITION trial) is evaluating the
cost effectiveness of screening and intensive treatment
of screen detected cases. A substudy6 of the ADDI-
TION (Cambridge) trial investigating the psychologi-
cal impact of screening reported minimal adverse
effect overall—no significant differences were found
between the screening and control participants on psy-
chological measures. People who screened positive at
the first test reported a significantly greater psycholo-
gical effect than those who screened negative, but
effects were small and mean scores were not clinically
relevant.6 At three to five months (after participants
had completed the screening process) and
12-15 months, the more tests a participant had before
screeningnegative, themore theyworried about devel-
oping diabetes.However, levels of worrywere low and
effect sizes small.6
Recent qualitative research has highlighted consid-
erable diversity in the emotional reactions of people
diagnosed with type 2 diabetes through routine testing
(compared with those diagnosed after illness)7 8 and a
lack of understanding of their risk of cardiovascular
disease.9 Only one qualitative study has explored
screening for type 2 diabetes from patients’
perspectives.10 This highlighted a lack of understand-
ing of the meaning of raised blood glucose. Few diag-
nosed patients thought their diabetes was a potentially
severe condition, and those who received negative
results (but were still at high risk) reported reassurance
and no plans to change their lifestyle. This study was
limited by a retrospective design, which could not
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capture the temporal relation between patients’ expec-
tations and experiences of the screening process or
which aspects of screening may have fostered the low
levels of anxiety observed. Furthermore, it only looked
at people with positive or negative results, not those
with intermediate results (impaired glucose tolerance
or impaired fasting glucose).
We devised a prospective qualitative study to pro-
vide insight into the factors that contribute to anxiety
during screening, as noted in the quantitative psycho-
logical impact substudy of ADDITION (Cambridge),
and to provide insight into expectations and reactions
to the screening experience of patients with positive,
negative, and intermediate results.
METHOD
Ourqualitative approach enabledus to identify themes
during data collection, rather than test predetermined
hypotheses.11 We incorporated a prospective compo-
nent to capture participants’ experiences and views at
different stages during the screening process and to
explore whether and how these changed after receiv-
ing their results.
Participants
We were keen to capture the experience of patients
through the entire stepwise screening process (box 1).
Because only 7% of people in ADDITION (Cam-
bridge) who took the first test (random blood glucose)
went on to take the final test (oral glucose tolerance) we
sampled at three stages:
(1) We began by sampling at the point of referral for
the final test; all patients with oral glucose tolerance
tests scheduled during a defined period were invited
for interview (n=65). The resulting sample com-
prised 13 participants who were interviewed both
before this test and again after receiving their test
results.
(2) A second group of participants (n=21) was pur-
posively invited for interview after their final test
results to redress the uneven balance of sex and
diagnosis achieved in the first group. The resulting
sample comprised five participants who were inter-
viewed once (after test results).
(3) To capture the views of participants at the initial
test (random blood glucose), we invited all patients
attending for tests during one practice session
(n=15). The resulting sample comprised five partici-
pants who were interviewed once, shortly after their
test.
All participants were patients at seven ADDITION
(Cambridge) study practices; recruitment was by
invitation letter with an opt-in reply slip. The table pro-
vides a breakdown of participants’ sex and diagnosis.
Data collection
HE conducted all interviews in participants’ homes or
workplaces. All patients gave written consent. Inter-
views covered the different stages of the screening pro-
cess (box 2). The initial question, “Thinking back to
when you received the invitation to screening what
were your initial feelings?” encouraged participants
to tell their story of the screening experience from the
beginning. Interviews were audio recorded and tran-
scribed verbatim.
Analysis
The analysis was informed by grounded theory, invol-
ving concurrent data collection and analysis, together
with systematic efforts to check and refine emerging
categories of data.14 15 Themes were not predeter-
mined; rather, those that emerged in early interviews
were discussed in team meetings (HE, RD, JL) and
Box 1 | The ADDITION (Cambridge) trial screening
programme
A stepwise screening procedure in people aged
40-69 years without known diabetes. People identified
in the top quartile of risk of having prevalent
undiagnosed type 2 diabetes by automated search of
medical records12 are invited by letter to attend their
local general practice for screening
Screening procedure
Visit 1: random whole blood (capillary) glucose and
glycosylated haemoglobin tests
 If random blood glucose 5.5-11.0 mmol/l proceed
to visit 2
 If random blood glucose ≥11.1mmol/l proceed to
visit 3
Visit 2: fasting whole blood (capillary) glucose
 If fasting blood glucose ≥6.1 mmol/l or fasting
blood glucose 5.5-6.0 mmol/l and glycosylated
haemoglobin (from visit 1) ≥6.1% proceed to visit 3
Visit 3 at hospital outpatient centre: oral glucose
tolerance test13 and clinical, anthropometric, and
biochemical measures
 Diagnosis of type2diabeteswasmadeaccording to
the World Health Organization criteria2
 A second (confirmatory) oral glucose tolerance test
was needed if a patient had tested 5.5-11.0mmol/l
at random blood glucose, 5.5-6.0 mmol/l at fasting
blood glucose, and glycosylated haemoglobin
≥6.1%
 Results were faxed to the patient’s general
practitioner for discussion with patients
Mean timing of (interview study) participants’ tests:
 Day 1 Invitation sent to patient
 Day 20 Attend random blood glucose
 Day 47 Attend fasting blood glucose
 Day 91 Attend oral glucose tolerance test
Final diagnosis of participants in a trial of screening for diabetes
Sex Type 2 diabetes
Impaired glucose
tolerance or impaired
fasting glucose Negative
Negative (random or
fasting blood glucose
only)
Male 5 6 1 2
Female 3 1 2 3
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were used to inform subsequent interviews and analy-
sis. Throughout the interview and analysis phases,
team meetings focused on exploring patients’ under-
lying reasoning, discussing deviant cases, and reaching
agreement on recurrent themes and findings. HE and
RD independently read through and cross compared
all transcripts.We usedNVivo7 (QSR International), a
qualitative data indexing package, to help in data cod-
ing and retrieval.
RESULTS
Participants’ accounts of their screening experience
showed how their perceptions of type 2 diabetes and
their own personal risk changed over the course of the
stepwise screening programme (box 1). Participants
seemed to undergo a process of psychological adjust-
ment, typically from attending the first screening test
without considering its implications, to the final test
where they confronted the possibility of having dia-
betes, as demonstrated by these contrasting quotes:
Patient 5 (male, impaired glucose tolerance, age 69)
“I wasn’t concerned at all, you know I thought, well I’ll
just go along and if I can help well okay all well and
good, go and see what happens.”
Patient 18 (female, impaired glucose tolerance, age
64) “So I go for number one, I go for number two and
then I have to go to number three. So it’s a build up all
the time, making me think, well OK there’s a possibi-
lity you know . . . there’s a strong possibility you know’
in that sense [. . .] you’ve gone through the three, so
your brain’s adjusted anyway.”
Initial stages of the screening process
Participants’ reflections on the initial ADDITION
invitation letter highlighted an unquestioning percep-
tion of screening being “good” (box 3). Most partici-
pants seemed to have considered the initial test
“routine” and thought little about the implications of
the possible results, an attitude typified by one
patient’s comment that “it can only be a good thing.”
Attenders rarely expected to test positive, except for
one woman who had a family history of diabetes. At
this point in the screening process, some participants
drew attention to their perceived lack of risk factors
such as not having a sweet tooth, whereas others down-
played risk factors such as being overweight. Some
participants did not know why they had been invited.
Most participants who tested positive on the first
occasion reported being “not unduly worried.” A
high random blood glucose concentration was often
attributed to the food consumed for breakfast or the
previous evening, or a healthy fluctuation. Participants
typically reported expecting the next (fasting) test to be
negative. Indeed the participants interviewed after the
first test all said they were not worried. Accounts of the
health professionals’ reassuring manner in giving
results, particularly their use of the term borderline,
seemed to contribute to this lack of concern in some
cases.
Prediagnostic test expectations
After testing positive at the second (fasting) test some
participants still expected to test negative at the oral
glucose tolerance test, one hypothesising that the
large number of patients referred for this test meant
that only a few would be diabetic. Others had moved
to accepting the possibility of type 2 diabetes, albeit a
“mild” easily controlled type, often justifying this belief
on the absence of symptoms.
All but one participant interviewed before their oral
glucose tolerance test seemed to have taken in informa-
tion about type 2 diabetes from the media or from
health professionals, friends, and family at this stage.
Some participants (without a family history) had iden-
tified people with type 2 diabetes within their own
Box 2 | Topic guide for interviews
Before oral glucose tolerance test
Invitation letter
Reactions to being invited for screening and reasons for
attending
Perceptions of personal susceptibility to diabetes
Random blood glucose test
Expectations of test
Perceptions and understanding of test result and its
implications
Fasting blood glucose test
Expectations of test
Perceptions and understanding of test result and its
implications
Oral glucose tolerance test
Expectation about test
Anticipated result
Type 2 diabetes
Awareness and understanding of the disease
Perceived seriousness of the disease
Ideas about the causes of the disease
After results of the oral glucose tolerance test
Oral glucose tolerance test and diagnosis
Reflections on expectations of the test
Perceptions and understanding of test result
Emotional reactions to the result
If result negative or impaired glucose tolerance
Perceptions of future disease susceptibility
Intention to implement lifestyle changes
Emotional reactions
If diagnosed with type 2 diabetes
Perceptions of the disease (including perceived
seriousness)
Emotional reactions
Views about information and advice from health
professionals
Intention to implement lifestyle changes
Screening programme
Good and bad aspects of testing procedures
Views about timing, location, and information provided
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networks, sometimes using them as a benchmark
againstwhich tomake favourable comparisons.Others
reported how diabetes did not seem to affect their
friends’ lives, furthering positive perceptions of it
being a controllable condition.
Reactions after diagnosis (box 4)
Newly diagnosed type 2 diabetes
The most common reaction to being diagnosed with
type 2 diabetes was to downplay its importance; only
one participant reported shock. Testing positive at the
first two tests seemed to lead participants to adjust their
expectations from testing negative to an increased like-
lihood of having diabetes. A few participants reported
symptoms, previously not considered relevant (such as
tiredness and thirst), that they now linked to type 2
diabetes.
The one participant to describe shockwas also afraid
about the severe consequences of type 2 diabetes. In
contrast, the rest emphasised the lack of severity they
associated with the disease. All newly diagnosed
patients talked confidently about their plans to control
the disease; in some cases a diet-only regimen fuelled
the perception that their diabetes was mild. Further-
more, most of this group reported being grateful that
the screening programme had identified their diabetes
at a treatable stage; indeedonepatient described it as “a
wake up call” to change his lifestyle.
Intermediate and negative results
Participants with intermediate (impaired fasting glu-
cose or impaired glucose tolerance) or negative oral
glucose tolerance test results suggested that they had
known they did not have diabetes despite their earlier
high readings. Some stated that they would have been
surprised if they had been diagnosed, which contrasts
with the lack of surprise reported by those who were.
Often this belief was reinforced by lack of symptoms,
despite being apparently aware of the disease’s early
asymptomatic period.
Many participants diagnosed with an intermediate
condition seemed confused. They appeared to be una-
ware of this diagnostic label or struggled to explain its
meaning, or had received seemingly confused mes-
sages from their general practitioner. Most patients
seemed unconcerned by their result, often normalising
the condition, and reported feeling reassured by their
general practitioner or nurse who had recommended
simply annual checks. This diagnosis had not triggered
lifestyle change even in thosewhohad expressed inten-
tions to change if diagnosed with type 2 diabetes in the
pretest interview. For example, one patient said before
his oral glucose tolerance test, “One knows there’s a
chance of it and I think one can then say, right, well if
that’s the case how do I deal with it and try and take
sensible precautions.”But after diagnosis he said, “And
so I was relieved not to have to have something else to
worry about.”
Only one participant, unhappy with his general
practitioner’s explanation, wanted further information
about impaired glucose tolerance. Participants diag-
nosed with intermediate conditions had mixed views
about their likelihood of getting type 2 diabetes in the
future. Some patients accepted that lifestyle change
would affect their risk of developing diabetes, but
none appeared to be aware of the risk of cardiovascular
disease associated with impaired fasting glucose or
impaired glucose tolerance.
Box 3 | Typical perceptions at initial stages of the screening process
Screening is good
Patient 8 (male, impaired glucose tolerance, age 64) “I didn’t really think too much
about it ’cause I’m a great believer in preventive medicine if you like. It’s like preventive
maintenance on the car ’cause if you do it beforehand it saves you a lot of problems
later down the line”
Patient 102 (female, random blood glucose only, age 69) “I mean it’s only been a pin
prick up to now hasn’t it?”
Expectations of initial test results
Patient 2 (male, type 2 diabetes, age 67) “I honestly thought I’d have a clear, I can’t
remember ever suffering from anything, effects of diabetes or anything. I’m grossly
overweight but apart from that”
Patient 17 (female, normal, age 58) “I thought I’ll just go along and I’d no reason to
think there might be anything [diabetes] . . . I’ve never had a particularly sweet tooth”
Patient 4 (female, type 2 diabetes, age 58) “I had been given these tests before frommy
doctor, because of my family. My grandmother and grandfather both had diabetes and
nine out of their 11 children had it, includingmymother. Andmy cousins have got it so I
would not be surprised if—it wouldn’t be a shock anyway”
Reflections on reason for being invited
Patient 11 (male, type 2 diabetes, age 55) “I suppose the criteria they put forward was
over 40 and overweight . . . I certainly unfortunately fit into that”
Patient 3 (male, normal, age 69) “No. No. I don’t know why I was invited, I think maybe
it’s because I’ve had hypertension ’cause they say that it can lead to diabetes, I don’t
know”
Patient 103 (male, random blood glucose only, 53) “It just said in the letter that I was
just picked at random”
Unimportant event
Patient 3 (male, normal, age 69) “I know it [random blood glucose] was quite high. But
I’d had rather a big meal the night before [. . .] a great big plate of ice cream and two
bananas which I imagine put the blood sugar up quite a lot”
Patient 5 (male, impaired glucose tolerance, age 69) “I was surprised at that initial test,
that it was higher than the ones I’ve been doing here, but I thought, well these things
happen. And I know with my wife at times her readings do fluctuate”
Patient 1 (male, type 2 diabetes, age 61) “[The nurse] said, ‘You’ll probably be quite all
right but you’re on the borderline so we’ll get you back just in case’”
Prediagnostic test expectations
Patient 2 (male, type 2 diabetes, age 67) “I’ve set my mind that I will probably fail (be
diagnosed) tomorrow. But if you catch it early enough you can probably get rid of most
of it just by dieting or looking after [yourself]”
Patient 1 (male, type 2 diabetes, age 61) “If I have got diabetes or any form of diabetes,
it’s very light anyway, you can control it quite easily. It’s not—I don’t think for one
minute I’ve got it life threatening. I would be dead by now wouldn’t I?”
Patient 8 (male, impaired glucose tolerance, age 64) “My cousin’s wife went along [. . .]
but it was off the Richter scale. I mean [her blood glucose level] was like 31 for Christ’s
sake. And even now with it controlled . . . it’s about 13. I said, “No I was something like
7.1 I think or 7”
Patient 6 (male, impaired fasting glucose, age 50) “Obviously I hope I’m not diabetic
and have to inject myself. I’ve got a couple of friends who are diabetic that do that. But
it doesn’t seem to have slowed them up too much or worry them”
RESEARCH
page 4 of 6 BMJ | ONLINE FIRST | bmj.com
DISCUSSION
This prospective qualitative study highlights the fluid
and changing nature of participants’ perceptions at dif-
ferent stages of a stepwise screening programme for
type 2 diabetes. The data indicate that participants
underwent a process of psychological adjustment as
they progressed through the programme. The findings
help to explain the low levels of anxiety seen among
participants in the ADDITION (Cambridge) screen-
ing programme, including those eventually diagnosed
with the disease.6
Although participants talked about diabetes screen-
ing being a good thing—enabling the disease to be
detected at an early, supposedly treatable stage—on a
personal level most tended to downplay or not engage
with their individual risk. Many participants, for
instance, talked about attending the first test without
considering the possibility of testing positive. Upon
receipt of a positive test, there was a tendency to use
an explanation other than diabetes and expect the next
test to be negative.
By the time of the final diagnostic (oral glucose tol-
erance) test, participants had had time (nine to
10 weeks) to take in diabetes related information
from the media or through conversations with friends,
family, or health professionals. They had typically
moved to accepting the increased possibility of being
diagnosed with type 2 diabetes, but of a mild and con-
trollable type. Minimising the threat of type 2 diabetes
in this way may have helped participants prepare
themselves mentally for a positive diagnosis, and
helps account for the lack of anxiety seen in the parti-
cipants who reached this stage of the programme.6
After diagnosis, the confidence that those diagnosed
with type 2 diabetes expressed in their plans to control
their disease seemed to be related to several percep-
tions and factors: the disease having been discovered
“at an early stage”, a lackof severe complications,16 and
being on a diet-only regimen.10 Our findings suggest
that the duration and stepwise nature of the screening
process is also salient, enabling gradual psychological
adjustment. However many stages there are in a
screening programme, people will have to go through
a process of readjusting their expectations of personal
risk. In the absence of a stepwise screening process,
psychological reactions might be different. Hence,
future research should compare the effect of a stepwise
screening programme with a one-off diagnostic oral
glucose tolerance test.
Patients with intermediate and negative results
Participants with impaired fasting glucose or impaired
glucose tolerance tended to lack awareness of this diag-
nosis or struggled to explain themeaning and its impli-
cations. These participants, and those with a negative
final test result, also expressed no intentions to change
their lifestyles, despite having high blood glucose con-
centrations in the first few tests and the increased
cardiovascular risk associated with impaired glucose
tolerance or impaired fasting glucose. Given that
many participants had not realised about these risks
earlier in the screening process, this finding is unsur-
prising. It may also indicate a lack of accepted profes-
sional understanding and management protocols for
treating patients at increased metabolic and cardio-
vascular risk, a problem previously raised by a qualita-
tive study with general practitioners.17
Implications
The findings have important implications for people
who implement screening. Even patients who tested
negative at the first two tests remain at high risk of
developing type 2 diabetes (as the risk score identified
them in the top quarter for risk).12 Hence, the minimal
importance attached to the first test, and relief arising
from a negative random or fasting blood glucose test,
could undermine the population benefit of a screening
programme if these people do not realise that their risk
remains high.18 Thus, patients should be made aware
of the risk factors that led to their screening invitation.
Furthermore, the lack of intentions to change lifestyle
in participants who did not test positive at the final
diagnosis raises questions of when and how “risk of
Box 4 | Reaction to diagnosis
Type 2 diabetes
Patient 9 (female, age 58) “Last time I saw you when we’d done the first interview, I
think I was quite sort of blasé . . . since I’ve been diagnosed I’m trying to get my head
around it, and I’m finding it difficult. [. . .] To put it plainly I’m scared”
Patient 10 (male, age 66) “I rather suspected that once having got as far as having to go
to [hospital], that [type 2 diabetes] was gonna be the outcome”
Patient 16 (female , age 63) “And I think there’s—that was where the tell-tale sign that I
had trouble . . . [my husband] used to say to me, ‘you drink too much bloomin’ water’”
Patient 10 (male, age 66) “It’s not like you’re being told you’ve got cancer, it’s only
diabetes for goodness sake innit? I mean, I must admit that everybody else seems to be
taking it much more seriously than I am”
Patient 2 (male, age 67) “He [general practitioner] explained that people call it a mild
form of the actual thing. But it wasn’t mild, that was wrong, it was a type. And there was
two ways of controlling it which was either tablets or diet, and they decided to go on the
diet this time with me” . . . “and if that don’t work well obviously it’s medication. But . . .
I’m quite confident that in myself that the diet will control it”
Patient 1 (male, age 61) “If it wasn’t for [ADDITION] it wouldn’t have been picked up
when it was, which means in a few years time I could be in some mess and it would be
far too late to do anything then”
No diabetes
Patient 3 (male, normal, age 69) “I didn’t really think that I’d got diabetes, ’cause I mean
you can usually get symptoms don’t you?”
Patient 13 (male, impaired fasting glucose, age 69) “There was one little glitch where
something showed up and it was very technical, about how quickly the blood can
absorb sugar or something”
Patient 14 (male, impaired glucose tolerance, age 69) “I come out okay, well I come out
—I come out with glucose intolerance, glucose impaired tolerance, which is below,
right? It means you’re not diabetic but you could be—if you go down the path of—you
know—that will bring you to it. And lots of people have got it haven’t they?”
Patient 15 (male, impaired glucose tolerance, age 53) “He [general practitioner] said,
‘Yeah, you’re fine, no problem . . . You’ve got a slight intolerance to glucose . . . No
problem, you’re just like the man next door.’ I said, ‘Yeah, but it all depends on what the
man next door’s like doesn’t it?’”
Patient 5 (male, impaired glucose tolerance, age 69) “I suppose depending upon what I
eat and do and that sort of thing. I suppose that’s the things that affect it and . . . I
suppose could tip it over into being a positive reading then”
RESEARCH
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diabetes” might be effectively conveyed to patients to
motivate changes in lifestyle. The interviews carried
out before the oral glucose tolerance test indicate that
this stage might be a useful point at which to give
patients information about the consequences of a posi-
tive or negative test, so that those not diagnosed with
type 2 diabetes are made aware of their risk of devel-
oping diabetes and cardiovascular disease.
The lack of anxiety associated with the screening
programme may suggest a low psychological cost to
implementing screening nationally. However, the ten-
dency not to perceive type 2 diabetes as a serious con-
dition is a potential concern. The information
conveyed to participants about their screening result
is key to their understanding.19 A challenge for health
professionals is to convey enough information about
the potential consequences of the disease to justify life-
style change, without raising anxiety sufficiently to
cause disengagement.7 The ADDITION (Cambridge)
trial produced protocols outlining the form of words to
be used when giving out results, but without observing
the tests it is impossible to knowwhat was actually said.
Hence, future research could look at diagnostic consul-
tations between health professionals and people with
screen detected type 2 diabetes and impaired fasting
glucose or impaired glucose tolerance.
Strengths and limitations of the study
The study was strengthened by its prospective compo-
nent, enabling investigation of participants’ views
before and after their final diagnosis. An additional
strength is its focus on reactions to intermediate results
as well as positive and negative diagnostic results. The
study’s generalisability may be limited by its reliance
on an opt-in procedure and low response rate. How-
ever, while it is impossible to establish whether partici-
pants weremore or less anxious about their health than
non-participants, the findings concur with previous
literature10 and the larger quantitative study.6
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WHAT IS ALREADY KNOWN ON THIS TOPIC
 Quantitative studies have reported a limited psychological effect of screening for type 2
diabetes
 Qualitative work has shown that patients with screen detected type 2 diabetes tend to think
their disease is not serious
WHAT THIS STUDY ADDS
 Participants’ perceptions of type 2 diabetes and their risk of developing the disease
changed over the course of a diabetes screening programme
 The stepwise nature of the screening programme seemed to facilitate psychological
adjustment
 Participants were uncertain about themeaning of intermediate screening results, and those
with negative results were unaware they remained at high risk
RESEARCH
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